Inhibitory Effect of Vonoprazan on the Metabolism of [ 14 C]Prasugrel in Human Liver Microsomes

ConclusionsThe in vitro data show that the pharmacodynamic interaction reported in the literature between vonoprazan and prasugrel is unlikely to be caused by CYP inhibition by vonoprazan. The results were similar to those obtained from the study with clopidogrel.
Source: European Journal of Drug Metabolism and Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research